Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Bladder Cancer × pembrolizumab × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 227 Melanoma 122 Squamous Cell Carcinoma of Head and Neck 119 Parkinson Disease 4, Autosomal Dominant Lewy Body 104 Neoplasm Metastasis 87 Triple Negative Breast Neoplasms 84 Lung Neoplasms 84 Neoplasms 76 Breast Neoplasms 71 Carcinoma, Renal Cell 62 Colorectal Neoplasms 60 Head and Neck Neoplasms 49 Stomach Neoplasms 44 Urinary Bladder Neoplasms 40 Ovarian Neoplasms 40 Carcinoma, Transitional Cell 38 Endometrial Neoplasms 37 Pancreatic Neoplasms 34 Carcinoma, Hepatocellular 33 Uterine Cervical Neoplasms 31 Prostatic Neoplasms 26 Esophageal Neoplasms 25 Glioblastoma 23 Carcinoma, Squamous Cell 23 Carcinoma 22 Recurrence 20 Brain Neoplasms 20 Skin Neoplasms 19 Sarcoma 19 Hodgkin Disease 19

Interventions

enfortumab vedotin 2 pembrolizumab 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346053 2026-01-16

Chrono-EVP

British Columbia Cancer Agency

Phase 3 Not yet recruiting

Advanced Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡